Studies on mouse and human p53 TS mutants demonstrated that they have potent apoptosis or cell cycle arrest activities at 32 °C, indicating that activating these mutants may produce anti-tumor effects due to their high expression levels. The gene discussed is TP53; the disease is neoplasm.